Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors

This publication has 48 references indexed in Scilit:

• Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways
  Blood, 2001
• Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor–induced proliferation and maturation
  Experimental Hematology, 2000
• Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors
  Leukemia, 1998
• BCR/ABL induces multiple abnormalities of cytoskeletal function.
  Journal of Clinical Investigation, 1997
• Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.
  Journal of Clinical Investigation, 1995
• Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
  Journal of Clinical Investigation, 1994
• Role of bone marrow matrix in normal and abnormal hematopoiesis
  Critical Reviews in Oncology/Hematology, 1994
• Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.
  The Journal of Experimental Medicine, 1991
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973